pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-451b |
Genomic Coordinates | chr17: 28861371 - 28861438 |
Description | Homo sapiens miR-451b stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-451b | ||||||||||||||
Sequence | 7| UAGCAAGAGAACCAUUACCAUU |28 | ||||||||||||||
Evidence | Experimental | ||||||||||||||
Experiments | Illumina | ||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||
SNPs in miRNA |
|
||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | LIMA1 | ||||||||||||||||||||
Synonyms | EPLIN, SREBP3 | ||||||||||||||||||||
Description | LIM domain and actin binding 1 | ||||||||||||||||||||
Transcript | NM_001113546 | ||||||||||||||||||||
Other Transcripts | NM_001113547 , NM_016357 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on LIMA1 | |||||||||||||||||||||
3'UTR of LIMA1 (miRNA target sites are highlighted) |
>LIMA1|NM_001113546|3'UTR 1 CAAATTGCAATGATGCTGGGCCTTAAATTCATGTTAGTGTTAGCGAGCCACTGCCCTTTGTCAAAATGTGATGCACATAA 81 GCAGGTATCCCAGCATGAAATGTAATTTACTTGGAAGTAACTTTGGAAAAGAATTCCTTCTTAAAATCAAAAACAAAACA 161 AAAAAACACAAAAAACACATTCTAAATACTAGAGATAACTTTACTTAAATTCTTCATTTTAGCAGTGATGATATGCATAA 241 GTGCTGTAAGGCTTGTAACTGGGGAAATATTCCACCTGATAATAGCCCAGATTCTACTGTATTCCCAAAAGGCAATATTA 321 AGGTAGACAGATGATTAGTAGTATATTGTTACACACTATTTTGGAATTAGAGAACATACAGAAGGAATTTAGGGGCTTAA 401 ACATTACGACTGAATGCACTTTAGTATAAAGGGCACAGTTTGTATATTTTTAAATGAATACCAATTTAATTTTTTAGTAT 481 TTACCTGTTAAGAGATTATTTAGTCTTTAAATTTTTTAGGTTAATTTTCTTGCTGTGATATATATGAGGAATTTACTACT 561 TTATGTCCTGCTCTCTAAACTACATCCTGAACTCGACGTCCTGAGGTATAATACAACAGAGCACTTTTTGAGGCAATTGA 641 AAAACCAACCTACACTCTTCGGTGCTTAGAGAGATCTGCTGTCTCCCAAATAAGCTTTTGTATCTGCCAGTGAATTTACT 721 GTACTCCAAATGATTGCTTTCTTTTCTGGTGATATCTGTGCTTCTCATAATTACTGAAAGCTGCAATATTTTAGTAATAC 801 CTTCGGGATCACTGTCCCCCATCTTCCGTGTTAGAGCAAAGTGAAGAGTTTAAAGGAGGAAGAAGAAAGAACTGTCTTAC 881 ACCACTTGAGCTCAGACCTCTAAACCCTGTATTTCCCTTATGATGTCCCCTTTTTGAGACACTAATTTTTAAATACTTAC 961 TAGCTCTGAAATATATTGATTTTTATCACAGTATTCTCAGGGTGAAATTAAACCAACTATAGGCCTTTTTCTTGGGATGA 1041 TTTTCTAGTCTTAAGGTTTGGGGACATTATAAACTTGAGTACATTTGTTGTACACAGTTGATATTCCAAATTGTATGGAT 1121 GGGAGGGAGAGGTGTCTTAAGCTGTAGGCTTTTCTTTGTACTGCATTTATAGAGATTTAGCTTTAATATTTTTTAGAGAT 1201 GTAAAACATTCTGCTTTCTTAGTCTTACCTAGTCTGAAACATTTTTATTCAATAAAGATTTTAATTAAAATTTGAACTTT 1281 TCAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 51474.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000552491.1 | 3UTR | UUAAUUUUCUUGCUGUGAUAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000552491.1 | 3UTR | UUAAUUUUCUUGCUGUGAUAUAUAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000552491.1 | 3UTR | UUAAUUUUCUUGCUGUGAUAUAUAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
124 hsa-miR-451b Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT060018 | VANGL2 | VANGL planar cell polarity protein 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT069874 | SRP54 | signal recognition particle 54 | ![]() |
![]() |
2 | 2 | ||||||
MIRT088316 | RAB10 | RAB10, member RAS oncogene family | ![]() |
![]() |
2 | 4 | ||||||
MIRT100747 | VEGFA | vascular endothelial growth factor A | ![]() |
![]() |
![]() |
![]() |
![]() |
5 | 12 | |||
MIRT152236 | ZNF460 | zinc finger protein 460 | ![]() |
![]() |
2 | 2 | ||||||
MIRT198492 | USP14 | ubiquitin specific peptidase 14 | ![]() |
![]() |
2 | 6 | ||||||
MIRT204750 | BZW1 | basic leucine zipper and W2 domains 1 | ![]() |
![]() |
2 | 12 | ||||||
MIRT211209 | FGF2 | fibroblast growth factor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT234352 | MSL1 | male specific lethal 1 homolog | ![]() |
![]() |
2 | 8 | ||||||
MIRT281810 | MAP2K1 | mitogen-activated protein kinase kinase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT369113 | CKMT1A | creatine kinase, mitochondrial 1A | ![]() |
![]() |
2 | 2 | ||||||
MIRT401349 | C5ORF51 | chromosome 5 open reading frame 51 | ![]() |
![]() |
2 | 4 | ||||||
MIRT441509 | ERN1 | endoplasmic reticulum to nucleus signaling 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT441888 | RD3 | retinal degeneration 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT443549 | GPR35 | G protein-coupled receptor 35 | ![]() |
![]() |
2 | 2 | ||||||
MIRT444959 | ADAM22 | ADAM metallopeptidase domain 22 | ![]() |
![]() |
2 | 2 | ||||||
MIRT445808 | NFATC2 | nuclear factor of activated T-cells 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT446509 | ASCC1 | activating signal cointegrator 1 complex subunit 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT447457 | ST18 | ST18, C2H2C-type zinc finger | ![]() |
![]() |
2 | 2 | ||||||
MIRT448296 | ZDHHC3 | zinc finger DHHC-type containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT463178 | ZNF281 | zinc finger protein 281 | ![]() |
![]() |
2 | 2 | ||||||
MIRT466606 | TBC1D13 | TBC1 domain family member 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT467235 | SPRED1 | sprouty related EVH1 domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT471039 | PISD | phosphatidylserine decarboxylase | ![]() |
![]() |
2 | 10 | ||||||
MIRT471892 | NUAK2 | NUAK family kinase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT474151 | LIMA1 | LIM domain and actin binding 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT474155 | LIFR | LIF receptor alpha | ![]() |
![]() |
2 | 2 | ||||||
MIRT481037 | BAZ2A | bromodomain adjacent to zinc finger domain 2A | ![]() |
![]() |
2 | 2 | ||||||
MIRT483083 | GPR75 | G protein-coupled receptor 75 | ![]() |
![]() |
2 | 4 | ||||||
MIRT485208 | PRKAR2A | protein kinase cAMP-dependent type II regulatory subunit alpha | ![]() |
![]() |
2 | 8 | ||||||
MIRT495187 | ST3GAL1 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT495431 | ATG7 | autophagy related 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT499160 | FAM83C | family with sequence similarity 83 member C | ![]() |
![]() |
2 | 6 | ||||||
MIRT499505 | GGA3 | golgi associated, gamma adaptin ear containing, ARF binding protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT500400 | ZMAT3 | zinc finger matrin-type 3 | ![]() |
![]() |
2 | 10 | ||||||
MIRT500684 | TRIM37 | tripartite motif containing 37 | ![]() |
![]() |
2 | 2 | ||||||
MIRT501301 | RPS6KB1 | ribosomal protein S6 kinase B1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT504339 | ASGR2 | asialoglycoprotein receptor 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT505931 | RCAN3 | RCAN family member 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT513196 | SLU7 | SLU7 homolog, splicing factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT521807 | POM121C | POM121 transmembrane nucleoporin C | ![]() |
![]() |
2 | 2 | ||||||
MIRT522779 | LAMP2 | lysosomal associated membrane protein 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT530179 | ZBED2 | zinc finger BED-type containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT532397 | SNX3 | sorting nexin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT532482 | HOXA13 | homeobox A13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT532538 | WDR13 | WD repeat domain 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT534779 | RAN | RAN, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT535719 | N4BP1 | NEDD4 binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT539310 | AKAP12 | A-kinase anchoring protein 12 | ![]() |
![]() |
2 | 4 | ||||||
MIRT539877 | RPL32 | ribosomal protein L32 | ![]() |
![]() |
2 | 2 | ||||||
MIRT539891 | IRGQ | immunity related GTPase Q | ![]() |
![]() |
2 | 2 | ||||||
MIRT540063 | CEP104 | centrosomal protein 104 | ![]() |
![]() |
2 | 2 | ||||||
MIRT540154 | GTF2B | general transcription factor IIB | ![]() |
![]() |
2 | 4 | ||||||
MIRT540206 | ARHGAP18 | Rho GTPase activating protein 18 | ![]() |
![]() |
2 | 2 | ||||||
MIRT540391 | CRTC1 | CREB regulated transcription coactivator 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT540595 | ERCC1 | ERCC excision repair 1, endonuclease non-catalytic subunit | ![]() |
![]() |
2 | 4 | ||||||
MIRT540733 | FABP2 | fatty acid binding protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT540949 | SLC25A43 | solute carrier family 25 member 43 | ![]() |
![]() |
2 | 2 | ||||||
MIRT541444 | C18orf32 | chromosome 18 open reading frame 32 | ![]() |
![]() |
2 | 4 | ||||||
MIRT541571 | ZNF43 | zinc finger protein 43 | ![]() |
![]() |
2 | 4 | ||||||
MIRT541601 | ALOX15 | arachidonate 15-lipoxygenase | ![]() |
![]() |
2 | 2 | ||||||
MIRT541933 | ORC1 | origin recognition complex subunit 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT542394 | WDR12 | WD repeat domain 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT542414 | SYNJ2BP | synaptojanin 2 binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT542481 | APOC3 | apolipoprotein C3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT542621 | XIAP | X-linked inhibitor of apoptosis | ![]() |
![]() |
2 | 2 | ||||||
MIRT542976 | FAM83F | family with sequence similarity 83 member F | ![]() |
![]() |
2 | 2 | ||||||
MIRT543741 | DHCR7 | 7-dehydrocholesterol reductase | ![]() |
![]() |
2 | 2 | ||||||
MIRT544594 | AP5Z1 | adaptor related protein complex 5 zeta 1 subunit | ![]() |
![]() |
2 | 4 | ||||||
MIRT546441 | SNX5 | sorting nexin 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT548213 | FKBP1A | FK506 binding protein 1A | ![]() |
![]() |
2 | 2 | ||||||
MIRT550471 | OSCAR | osteoclast associated, immunoglobulin-like receptor | ![]() |
![]() |
2 | 4 | ||||||
MIRT555230 | PRKAA1 | protein kinase AMP-activated catalytic subunit alpha 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT555428 | PPAP2B | phospholipid phosphatase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT556368 | MAF | MAF bZIP transcription factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT558149 | ELK4 | ELK4, ETS transcription factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT566181 | PTPN14 | protein tyrosine phosphatase, non-receptor type 14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT568468 | ARMC12 | armadillo repeat containing 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT607594 | TANGO2 | transport and golgi organization 2 homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT617588 | NDUFB5 | NADH:ubiquinone oxidoreductase subunit B5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT621244 | SIGLEC9 | sialic acid binding Ig like lectin 9 | ![]() |
![]() |
2 | 4 | ||||||
MIRT623679 | HOXD4 | homeobox D4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT625989 | FGFR1OP | FGFR1 oncogene partner | ![]() |
![]() |
2 | 4 | ||||||
MIRT627244 | ZBTB3 | zinc finger and BTB domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT632946 | ELOVL6 | ELOVL fatty acid elongase 6 | ![]() |
![]() |
2 | 4 | ||||||
MIRT635872 | SLC11A2 | solute carrier family 11 member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT636638 | CHAF1B | chromatin assembly factor 1 subunit B | ![]() |
![]() |
2 | 2 | ||||||
MIRT643563 | WDR73 | WD repeat domain 73 | ![]() |
![]() |
2 | 2 | ||||||
MIRT647907 | CIRH1A | UTP4, small subunit processome component | ![]() |
![]() |
2 | 2 | ||||||
MIRT652503 | TMEM170A | transmembrane protein 170A | ![]() |
![]() |
2 | 2 | ||||||
MIRT652843 | TACO1 | translational activator of cytochrome c oxidase I | ![]() |
![]() |
2 | 2 | ||||||
MIRT653299 | SMUG1 | single-strand-selective monofunctional uracil-DNA glycosylase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT659383 | CREG2 | cellular repressor of E1A stimulated genes 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT661339 | TBC1D15 | TBC1 domain family member 15 | ![]() |
![]() |
2 | 2 | ||||||
MIRT662372 | ANKRD42 | ankyrin repeat domain 42 | ![]() |
![]() |
2 | 2 | ||||||
MIRT664322 | CD209 | CD209 molecule | ![]() |
![]() |
2 | 2 | ||||||
MIRT671759 | F11R | F11 receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT673240 | KLHDC8A | kelch domain containing 8A | ![]() |
![]() |
2 | 2 | ||||||
MIRT682871 | C9orf156 | tRNA methyltransferase O | ![]() |
![]() |
2 | 2 | ||||||
MIRT683171 | SF3A1 | splicing factor 3a subunit 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT684262 | TBXA2R | thromboxane A2 receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT684395 | MCTS1 | MCTS1, re-initiation and release factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT684883 | P4HB | prolyl 4-hydroxylase subunit beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT686650 | TMEM184C | transmembrane protein 184C | ![]() |
![]() |
2 | 2 | ||||||
MIRT687771 | KIAA0355 | KIAA0355 | ![]() |
![]() |
2 | 2 | ||||||
MIRT694352 | CHST6 | carbohydrate sulfotransferase 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT696347 | SLC35D2 | solute carrier family 35 member D2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT700480 | PUM1 | pumilio RNA binding family member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT705909 | ADAM9 | ADAM metallopeptidase domain 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT714076 | FNDC3B | fibronectin type III domain containing 3B | ![]() |
![]() |
2 | 2 | ||||||
MIRT714401 | FBXO31 | F-box protein 31 | ![]() |
![]() |
2 | 2 | ||||||
MIRT716442 | RPS24 | ribosomal protein S24 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718204 | PSMF1 | proteasome inhibitor subunit 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT721238 | CRCP | CGRP receptor component | ![]() |
![]() |
2 | 2 | ||||||
MIRT721271 | SH3D19 | SH3 domain containing 19 | ![]() |
![]() |
2 | 2 | ||||||
MIRT721603 | ZNF484 | zinc finger protein 484 | ![]() |
![]() |
2 | 2 | ||||||
MIRT722916 | COA4 | cytochrome c oxidase assembly factor 4 homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT723457 | CUL4A | cullin 4A | ![]() |
![]() |
2 | 2 | ||||||
MIRT733813 | KREMEN1 | kringle containing transmembrane protein 1 | ![]() |
![]() |
2 | 0 | ||||||
MIRT733814 | CASK | calcium/calmodulin dependent serine protein kinase | ![]() |
![]() |
2 | 0 | ||||||
MIRT733815 | KLF4 | Kruppel like factor 4 | ![]() |
![]() |
2 | 0 | ||||||
MIRT733816 | BCL2 | BCL2, apoptosis regulator | ![]() |
![]() |
2 | 0 | ||||||
MIRT733817 | PCNA | proliferating cell nuclear antigen | ![]() |
![]() |
2 | 0 | ||||||
MIRT733818 | BAX | BCL2 associated X, apoptosis regulator | ![]() |
![]() |
2 | 0 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|